Dinos G, Synetos D, Coutsogeorgopoulos C
Laboratory of Biochemistry, School of Medicine, University of Patras, Greece.
Biochemistry. 1993 Oct 12;32(40):10638-47. doi: 10.1021/bi00091a014.
The inhibition of peptide bond formation by spiramycin was studied in an in vitro system derived from Escherichia coli. Peptide bonds are formed between puromycin (S) and Ac-Phe-tRNA, which is a component of complex C, i.e., of the [Ac-Phe-tRNA-70S ribosome-poly(U)] complex, according to the puromycin reaction: C+S (Ks)<==>CS (k3)==>C'+P [Synetos, D., & Coutsogeorgopoulos, C. (1987) Biochim. Biophys. Acta 923, 275-285]. It is shown that spiramycin (A) reacts with complex C and forms the spiramycin complex CA, which is inactive toward puromycin. CA is the tightest complex formed between complex C and any of a number of antibiotics, such as chloramphenicol, blasticidin S, lincomycin, or sparsomycin. CA remains stable following gel chromatography on Sephadex G-200 and sucrose gradient ultracentrifugation. Detailed kinetic study suggests that CA is formed in a variation of a two-step mechanism in which the initial encounter complex CA is kinetically insignificant and CA is the product of a conformational change of complex CA according to the equation, C+A (kassoc)<==>(kdissoc) CA. The rate constants of this reaction (spiramycin reaction) are kassoc = 3.0 x 10(4) M-1 s-1 and kdissoc = 5.0 x 10(-5) s-1. Such values allow the classification of spiramycin as a slow-binding, slowly reversible inhibitor; they also lead to the calculation of an apparent overall dissociation constant equal to 1.8 nM for the CA complex. Furthermore, they render spiramycin a useful tool in the study of antibiotic action on protein synthesis in vitro. Thus, the spiramycin reaction, in conjunction with the puromycin reaction, is applied (i) to detect a strong preincubation effect exerted by chloramphenicol and lincomycin (this effect constitutes further evidence that these two antibiotics combine with complex C as slow-binding inhibitors) and (ii) to determine the rate constant for the regeneration (k7 = 2.0 x 10(-3) s-1) of complex C from the sparsomycin complex CI [Theocharis, D. A., & Coutsogeorgopoulos, C. (1992) Biochemistry 31, 5861-5868] according to the equation, C+I (Ki)<==>CI (k6)<==>(k7) CI. The determination of k7 enables us to calculate the apparent association rate constant of sparsomycin, (k7/Ki') = 1.0 x 10(5) M-1 s-1, where Ki' = Ki(k7/k6 + k7). It is also shown that Ac-Phe-tRNA bound to the sparsomycin complex CI is protected against attack by hydroxylamine.(ABSTRACT TRUNCATED AT 400 WORDS)
在源自大肠杆菌的体外系统中研究了螺旋霉素对肽键形成的抑制作用。根据嘌呤霉素反应,肽键在嘌呤霉素(S)与Ac-Phe-tRNA之间形成,Ac-Phe-tRNA是复合物C的一个组分,即[Ac-Phe-tRNA-70S核糖体-聚(U)]复合物的组分:C+S(Ks)<==>CS(k3)==>C'+P [西内托斯,D.,& 库索乔治奥普洛斯,C.(1987年)《生物化学与生物物理学报》923,275 - 285]。结果表明,螺旋霉素(A)与复合物C反应并形成螺旋霉素复合物CA,其对嘌呤霉素无活性。CA是复合物C与多种抗生素(如氯霉素、杀稻瘟菌素S、林可霉素或稀疏霉素)形成的最紧密复合物。在Sephadex G - 200上进行凝胶色谱和蔗糖梯度超速离心后,CA保持稳定。详细的动力学研究表明,CA是通过两步机制的变体形成的,其中初始碰撞复合物CA在动力学上不重要,CA是复合物CA构象变化的产物,根据方程:C+A(kassoc)<==>(kdissoc)CA。该反应(螺旋霉素反应)的速率常数为kassoc = 3.0×10⁴ M⁻¹ s⁻¹和kdissoc = 5.0×10⁻⁵ s⁻¹。这些值使螺旋霉素可归类为慢结合、缓慢可逆抑制剂;它们还导致计算出CA复合物的表观总解离常数等于1.8 nM。此外,它们使螺旋霉素成为体外研究抗生素对蛋白质合成作用的有用工具。因此,螺旋霉素反应与嘌呤霉素反应一起应用于:(i)检测氯霉素和林可霉素产生的强烈预孵育效应(这种效应进一步证明这两种抗生素作为慢结合抑制剂与复合物C结合);(ii)根据方程:C+I(Ki)<==>CI(k6)<==>(k7)CI,确定从稀疏霉素复合物CI再生复合物C的速率常数(k7 = 2.0×10⁻³ s⁻¹)[西奥查里斯,D. A.,& 库索乔治奥普洛斯,C.(1992年)《生物化学》31,5861 - 5868]。k7的测定使我们能够计算稀疏霉素的表观缔合速率常数,(k7/Ki') = 1.0×10⁵ M⁻¹ s⁻¹,其中Ki' = Ki(k7/k6 + k7)也表明与稀疏霉素复合物CI结合的Ac-Phe-tRNA受到羟胺攻击的保护。(摘要截短于400字)